Cargando…
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
BACKGROUND: The purpose of this open-label study was to investigate the effect of a curcumin-phospholipid (lecithin, Meriva(®)) formulation (Norflo(®) tablet) on visual acuity and retinal thickness in patients with acute or chronic central serous chorioretinopathy. METHODS: Visual acuity was assesse...
Autor principal: | Mazzolani, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373230/ https://www.ncbi.nlm.nih.gov/pubmed/22701080 http://dx.doi.org/10.2147/OPTH.S31859 |
Ejemplares similares
-
Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
por: Mazzolani, Fabio, et al.
Publicado: (2013) -
Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022) -
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
por: Alishiri, Aliagha, et al.
Publicado: (2019) -
Central serous chorioretinopathy following oral quetiapine
por: Durmaz Engin, Ceren, et al.
Publicado: (2023) -
Advances in the treatment of central serous chorioretinopathy
por: Abouammoh, Marwan A.
Publicado: (2015)